Implications for practice and research: >Largest meta-analysis for Generalised Anxiety Disorder (GAD) to date synthesising 89 trials. >Adds ability to make research-based clinical decisions about medications for GAD that were not only funded from pharmaceutical companies. >Future research, to determine the benefits of these identified medications concurrently with GAD and depression, may be a clinically helpful next step. To read the full article, log in using your NHS OpenAthens details.